138 results
8-K
EX-10.4
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.3
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.2
DYAI
Dyadic International Inc., DE
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
wk2dz20kcfv5ajs7
11 Mar 24
Dyadic Announces Closing of Private Placement of
8:45am
8-K
EX-10.1
mbu f0blb
19 Sep 23
Dyadic Announces Development and License Agreement to Commercialize Animal-Free Alternative Proteins Using DapibusTM
8:30am
8-K
EX-10.1
6e1x6y ubcc
12 Apr 23
Dyadic Announces Expanded Licensing Agreement to Develop and Commercialize Vaccines and Biologics for African Continent
8:30am
8-K
EX-10.1
413k9ck
23 Jan 23
Dyadic Announces Sale of Equity Interest in Alphazyme
5:22pm
8-K
EX-10.1
93w290
11 May 22
Dyadic Announces Research, License and Collaboration for the Manufacture of
9:57am
8-K
EX-10.1
jc4n b5mcd7y
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
8-K
EX-10.1
460ni tt7w7ck
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-10.1
j9tk1fi
11 Aug 21
Entry into a Material Definitive Agreement
8:32am
8-K
EX-10.3
fw11 ndgpg6d02jocu
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
agiw8d8ryzrj 4g7g
27 Jul 21
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.2
f8yougs
27 Jul 21
Entry into a Material Definitive Agreement
8:33am